Special Interest Group (SIG)
RiHN Special Interest Group (SIG) on Point-of-Care Manufacture in Healthcare.
This Special Interest Group (SIG) will bring together and engage with key stakeholders; across the industry, academia, and government, involved in the Point-of-Care (POC) manufacturing in healthcare. Headed by a small steering committee involved in manufacturing research and innovation, we seek to evaluate the business case for POC manufacturing and shape future programmes in the sector.
Our focal areas:
- Improve understanding of key factors affecting POC manufacturing innovation adoption.
- Analyse the evidence of current and future POC performance, to identify SIG opportunities.
- Inform targeted investment in POC research, technology, and collaboration; backed up by data from SIG members.
- Support interactions with RiHN’s funded feasibility studies, and core team.
- Facilitate networking between manufacturing engineering and the clinical community.
- Provide foundations for future collaborative bids and projects.
We are planning a series of virtual workshops and in-person events (lockdown restrictions permitting), to facilitate sharing expertise and experience amongst SIG members. SIG members participating in events can expect materials generated at workshop events will be kept anonymous but may be captured as evidence for future case studies and paper collaborations.
SIG membership is free. Please enter your details below to join.
Join our Special Interest Group
SIG's Latest Events...
SIG'S first Point-of-Care Manufacturing Special Interest Group
This event by the Special Interest Group Event of Point of Care Manufacturing, is the first in a series of events held by RiHN based on the technology themes that we are focussed on. This first event looked at additive layer manufacturing and pharmaceutical manufacturing in the point-of-care scenario. The speakers are experts in their respective fields and we examined the business case for each technology field as well as how this applies to two of the RiHN feasibility studies. There was additional discussions at the end of each session to examine PoC in each scenario in further depth.
Register here for our second event...
The RiHN invites members to discuss the particular challenges and opportunities that RDM offers, particularly point of care manufacturing. Having previously identified the four major technology themes that offer the best benefit to healthcare, we now turn our attention to how manufacturing at the point of care redefines the business case and the operational requirements to do so. We intend to support the talks with insight from member polls, our steering board, major stakeholders and champions for RDM.
Our next event will be Clinical Fluids, and Cell and Tissue Manufacturing on Tuesday 7 December 2021 from 9:30am to 12:00pm which will be held online.
Speakers confirmed so far;
Prof. Darren Reynolds, UWE Bristol – Darren is lead PI for one of the RiHN feasibility studies, developing clinical-grade water at the point of need. The technology is being developed with a number of partners and with support for field testing from humanitarian organisations.
Date: 07 December 2021
Time: 09:30 – 12:00 GMT